AFROCENTRIC INVESTMENT CORPORATION LIMITED - Dealings in securities by a Director of a major subsidiary relating to vesting of shares under the LTIP

Dealings in securities by a Director of a major subsidiary relating to vesting of shares under the
LTIP

AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT      ISIN: ZAE000078416
(“AfroCentric” or “the Company”)


Dealings in securities by a Director of a major subsidiary of AfroCentric relating to vesting of shares under the
LTIP


In compliance with paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements, the Company
hereby discloses the following trades by a Director of Medscheme Holdings Limited (“Medscheme”) being a
major subsidiary of AfroCentric relating to the acceptance of Share Awards awarded in terms of the rules of
the AfroCentric Long Term Incentive Plan (“LTIP”) and are advised of the following information relating to
the vesting of Share Awards in respect of the first tranche (being 1/3rd of Share Awards after the expiry of
Retention Period i.e. in year 3 (three) after Award Date). The price per share, for purposes of determining
the market value, is the 30 day VWAP price per AfroCentric share on 30 October 2020 being 357 cent per
share:


 Name of director:                            Aklaaq Ahmed Mahmood
 Designation:                                 Executive Director of Medscheme, a major subsidiary of
                                              the Company
 Date of transaction:                         16 November 2020
 Nature of transaction:                       Acceptance of Share Awards in terms of the Company’s
                                              LTIP
 Class of security:                           Ordinary shares
 Number of securities:                        50 000
 Price per security:                          357 cents per share
 Value of transaction:                        R178 500.00
 Nature of interest:                          Direct Beneficial
 Clearance obtained:                          Yes



Johannesburg
17 November 2020

Sponsor
Sasfin Capital (a member of the Sasfin group)

Date: 17-11-2020 11:17:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.